H.C. Wainwright Reiterates Buy Rating on Syndax Pharmaceuticals (SNDX)

June 12, 2026 6:53 AM

H.C. Wainwright analyst Andres Maldonado reiterated a Buy rating and $40.00 price target on Syndax Pharmaceuticals (NASDAQ: SNDX).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found